Andrea Watson, RN, BSN, OCN
Saint Luke's Koontz Center for Advanced Breast Cancer, Kansas City, MOAuthored Items
November 14, 2017 | November 2017 Vol 8, No 11
Endocrine therapy is recommended for patients with hormone receptor–positive (HR+) advanced and metastatic breast cancer without visceral crisis (symptomatic visceral disease).
Last modified: June 5, 2018